- Home
- PMCB vs KRKR Comparison
PMCB vs KRKR Comparison
Compare PMCB & KRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- KRKR
- Stock Information
- Founded
- PMCB 1996
- KRKR 2010
- Country
- PMCB United States
- KRKR China
- Employees
- PMCB N/A
- KRKR N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- KRKR Business Services
- Sector
- PMCB Health Care
- KRKR Consumer Discretionary
- Exchange
- PMCB Nasdaq
- KRKR Nasdaq
- Market Cap
- PMCB 11.4M
- KRKR 9.1M
- IPO Year
- PMCB N/A
- KRKR 2019
- Fundamental
- Price
- PMCB $1.30
- KRKR $4.10
- Analyst Decision
- PMCB
- KRKR
- Analyst Count
- PMCB 0
- KRKR 0
- Target Price
- PMCB N/A
- KRKR N/A
- AVG Volume (30 Days)
- PMCB 15.1K
- KRKR 19.8K
- Earning Date
- PMCB 03-17-2025
- KRKR 03-11-2025
- Dividend Yield
- PMCB N/A
- KRKR N/A
- EPS Growth
- PMCB N/A
- KRKR N/A
- EPS
- PMCB 1.29
- KRKR N/A
- Revenue
- PMCB N/A
- KRKR $31,657,328.00
- Revenue This Year
- PMCB N/A
- KRKR $182.55
- Revenue Next Year
- PMCB N/A
- KRKR N/A
- P/E Ratio
- PMCB $1.00
- KRKR N/A
- Revenue Growth
- PMCB N/A
- KRKR N/A
- 52 Week Low
- PMCB $1.22
- KRKR $2.76
- 52 Week High
- PMCB $2.55
- KRKR $12.99
- Technical
- Relative Strength Index (RSI)
- PMCB 33.22
- KRKR 49.02
- Support Level
- PMCB $1.22
- KRKR $3.93
- Resistance Level
- PMCB $1.58
- KRKR $4.26
- Average True Range (ATR)
- PMCB 0.14
- KRKR 0.22
- MACD
- PMCB -0.04
- KRKR 0.03
- Stochastic Oscillator
- PMCB 15.59
- KRKR 42.83
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.
About KRKR 36Kr Holdings Inc.
36KR Holdings Inc is a holding company and conducts its business mainly through its subsidiaries, a VIE, and subsidiaries of the VIE. The Group is engaging in providing content and business services to new economy participants in the PRC. Its content production process includes content creation, content editing, screening and monitoring, and content distribution. The Group mainly generates revenues from providing online advertising services, enterprise value-added services, and subscription services. The Group's principal operations and geographic markets are substantially located in PRC.